BNP Paribas Financial Markets
INBX icon

BNP Paribas Financial Markets’s Inhibrx INBX Stock Holding History

BNP Paribas Financial Markets’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Buy
59,841
+27,302
+84% +$2.74M ﹤0.01% 2002
2026
Q1 		$2.19M Buy
32,539
+17,689
+119% +$1.31M ﹤0.01% 2608
2025
Q4 		$1.17M Buy
14,850
+12,964
+687% +$883K ﹤0.01% 2997
2025
Q3 		$63.5K Buy
1,886
+789
+72% +$19.4K ﹤0.01% 4494
2025
Q2 		$15.7K Buy
1,097
+254
+30% +$3.28K ﹤0.01% 4705
2025
Q1 		$11.8K Sell
843
-7,483
-90% -$102K ﹤0.01% 4678
2024
Q4 		$128K Buy
8,326
+543
+7% +$8.27K ﹤0.01% 4070
2024
Q3 		$122K Buy
7,783
+6,678
+604% +$93.8K ﹤0.01% 3408
2024
Q2 		$15.7K Buy
+1,105
New +$17.3K ﹤0.01% 3669

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets's INBX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Inhibrx (INBX) stake by 84% in Q2 2026, buying an estimated $2.74M and bringing the position to 59,841 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

BNP Paribas Financial Markets first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 148 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • BNP Paribas Financial Markets held 59,841 shares of Inhibrx worth $5.67M as of Q2 2026.
  • BNP Paribas Financial Markets bought 27,302 Inhibrx shares in Q2 2026, an estimated $2.74M.
  • Inhibrx made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2002 holding.
  • BNP Paribas Financial Markets first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 148 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.